{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:28:21Z","timestamp":1760149701148,"version":"build-2065373602"},"reference-count":68,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T00:00:00Z","timestamp":1694304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>Cutaneous leishmaniasis incidence has been rising in the past couple of decades. Standard therapy often includes antileishmanial drugs; however, due to their low safety and toxicity threshold, alternative treatments are being investigated. The association between COVID-19 and cutaneous leishmaniasis remains unclear and exploring this connection may offer crucial insights into the pathophysiology of and treatment strategies for infected patients. In this article, we describe a case of a male patient with a history of cardiac and other comorbidities who presented with cutaneous leishmaniasis in the form of impetigo-like skin lesions after being infected with COVID-19. Due to the patient\u2019s poor cardiac profile, sodium stibogluconate was not used and an alternative therapeutic approach was employed. The patient was treated with oral terbinafine, cryotherapy on specific lesions, and a course of cephalexin. Following the course of treatment and subsequent follow-up, the patient exhibited complete resolution and healing of the lesions with scarring, and no active lesions or recurrence were observed. This case highlights the potential for alternative treatment strategies for cutaneous leishmaniasis in patients with comorbidities and emphasizes the importance of further research to better understand the link between COVID-19 and cutaneous leishmaniasis.<\/jats:p>","DOI":"10.3390\/tropicalmed8090443","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T09:09:21Z","timestamp":1694423361000},"page":"443","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impetiginous Cutaneous Leishmaniasis after COVID-19 Infection in a Patient with Poor Cardiac Profile: A Case Report and Literature Review"],"prefix":"10.3390","volume":"8","author":[{"given":"Hend","family":"Alotaibi","sequence":"first","affiliation":[{"name":"Department of Dermatology, College of Medicine, King Saud University, Riyadh 11472, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6791-629X","authenticated-orcid":false,"given":"Abdulelah","family":"Aldossari","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud University, Riyadh 11472, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan","family":"Alnasser","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud University, Riyadh 11472, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,10]]},"reference":[{"key":"ref_1","unstructured":"Global Burden of Disease Study 2019 (GBD 2019) (2023, August 16). Data Resources|GHDx. Available online: https:\/\/ghdx.healthdata.org\/gbd-2019."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bern, C., Maguire, J.H., and Alvar, J. (2008). Complexities of Assessing the Disease Burden Attributable to Leishmaniasis. PLoS Negl. Trop. Dis., 2.","DOI":"10.1371\/journal.pntd.0000313"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bailey, F., Mondragon-Shem, K., Hotez, P., Ruiz-Postigo, J.A., Al-Salem, W., Acosta-Serrano, \u00c1., and Molyneux, D.H. (2017). A New Perspective on Cutaneous Leishmaniasis\u2014Implications for Global Prevalence and Burden of Disease Estimates. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005739"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bailey, F., Mondragon-Shem, K., Haines, L.R., Olabi, A., Alorfi, A., Ruiz-Postigo, J.A., Alvar, J., Hotez, P., Adams, E.R., and V\u00e9lez, I.D. (2019). Cutaneous Leishmaniasis and Co-Morbid Major Depressive Disorder: A Systematic Review with Burden Estimates. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007092"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4269\/ajtmh.2010.09-0235","article-title":"Estimation of Under-Reporting of Visceral Leishmaniasis Cases in Bihar, India","volume":"82","author":"Singh","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous Leishmaniasis","volume":"25","author":"Bailey","year":"2007","journal-title":"Clin. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijid.2014.04.023","article-title":"Revisiting Leishmaniasis in the Time of War: The Syrian Conflict and the Lebanese Outbreak","volume":"29","author":"Alawieh","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2230.2004.01605.x","article-title":"The Psychological Impact of Cutaneous Leishmaniasis","volume":"29","author":"Yanik","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kassi, M., Kassi, M., Afghan, A.K., Rehman, R., and Kasi, P.M. (2008). Marring Leishmaniasis: The Stigmatization and the Impact of Cutaneous Leishmaniasis in Pakistan and Afghanistan. PLoS Negl. Trop. Dis., 2.","DOI":"10.1371\/journal.pntd.0000259"},{"key":"ref_10","first-page":"474","article-title":"Quality of Life in Patients with Cutaneous Leishmaniasis","volume":"16","author":"Vares","year":"2013","journal-title":"Arch. Iran Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4269\/ajtmh.2009.80.574","article-title":"Association of Treatment of American Cutaneous Leishmaniasis Prior to Ulcer Development with High Rate of Failure in Northeastern Brazil","volume":"80","author":"Unger","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_12","first-page":"CD005067","article-title":"Interventions for Old World Cutaneous Leishmaniasis","volume":"11","author":"Pinart","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_13","first-page":"8","article-title":"Interventions for American Cutaneous and Mucocutaneous Leishmaniasis","volume":"2020","author":"Pinart","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"105089","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105089","article-title":"COVID-19 Pandemic and Burden of Non-Communicable Diseases: An Ecological Study on Data of 185 Countries","volume":"29","author":"Azarpazhooh","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous Leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yad\u00c33n, Z.E., Quigley, M.A., Davies, C.R., Rodrigues, L.C., and Segura, E.L. (2001). Assessment of Leishmaniasis Notification System in Santiago Del Estero, Argentina, 1990\u20131993. Am. J. Trop. Med. Hyg., 65, 27\u201330.","DOI":"10.4269\/ajtmh.2001.65.27"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1179\/000349803225002516","article-title":"HIV and the Transmission of Leishmania","volume":"97","author":"Molina","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug Resistance in Leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Alvar, J., V\u00e9lez, I.D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., den Boer, M., and WHO Leishmaniasis Control Team (2012). Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035671"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1128\/IAI.70.12.6734-6740.2002","article-title":"Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis Patients","volume":"70","author":"Bacellar","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0100-879X1998000100020","article-title":"Cytokine Profile and Pathology in Human Leishmaniasis","volume":"31","author":"Almeida","year":"1998","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-3024.2009.01125.x","article-title":"Recruitment of CD8(+) T Cells Expressing Granzyme A Is Associated with Lesion Progression in Human Cutaneous Leishmaniasis","volume":"31","author":"Faria","year":"2009","journal-title":"Parasite Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/IAI.02404-14","article-title":"Protective and Pathological Functions of CD8+ T Cells in Leishmania Braziliensis Infection","volume":"83","author":"Cardoso","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-4362.1995.tb00613.x","article-title":"Polar and Subpolar Diffuse Cutaneous Leishmaniasis in Brazil: Clinical and Immunopathologic Aspects","volume":"34","author":"Barral","year":"1995","journal-title":"Int. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/eji.1830270409","article-title":"Interleukin-10 and Interleukin-4 Inhibit Intracellular Killing of Leishmania Infantum and Leishmania Major by Human Macrophages by Decreasing Nitric Oxide Generation","volume":"27","author":"Vouldoukis","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/eji.1830221006","article-title":"The Microbicidal Activity of Interferon-Gamma-Treated Macrophages against Trypanosoma Cruzi Involves an L-Arginine-Dependent, Nitrogen Oxide-Mediated Mechanism Inhibitable by Interleukin-10 and Transforming Growth Factor-Beta","volume":"22","author":"Gazzinelli","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijid.2021.09.050","article-title":"Prophylactic Effect of Cutaneous Leishmaniasis against COVID-19: A Case-Control Field Assessment","volume":"122","author":"Bamorovat","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","article-title":"High Incidence of Epstein\u2013Barr Virus, Cytomegalovirus, and Human-Herpes Virus-6 Reactivations in Critically Ill Patients with COVID-19","volume":"51","author":"Simonnet","year":"2021","journal-title":"Infect. Dis. Now"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s13054-020-03252-3","article-title":"Herpes Simplex Virus and Cytomegalovirus Reactivations among Severe COVID-19 Patients","volume":"24","author":"Pinceaux","year":"2020","journal-title":"Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3851\/IMP3382","article-title":"COVID-19 and Hepatitis B Infection","volume":"25","author":"Alqahtani","year":"2020","journal-title":"Antivir. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102241","DOI":"10.1016\/j.parint.2020.102241","article-title":"Giardiasis Reactivation during Severe SARS-CoV-2 Infection","volume":"80","author":"Lupia","year":"2021","journal-title":"Parasitol. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e01358","DOI":"10.1016\/j.idcr.2021.e01358","article-title":"Visceral Leishmaniasis and COVID-19 Coinfection\u2014A Case Report","volume":"27","author":"Pikoulas","year":"2021","journal-title":"IDCases"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3201\/eid2705.204661","article-title":"Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020","volume":"27","author":"Heaney","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijid.2003.10.006","article-title":"Cutaneous Leishmaniasis: A 46-Year Study of the Epidemiology and Clinical Features in Saudi Arabia (1956\u20132002)","volume":"8","author":"AbuKhamsin","year":"2004","journal-title":"Int. J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/j.ijid.2012.11.015","article-title":"Molecular Characterization of Cutaneous Leishmaniasis in Al-Madinah Al-Munawarah Province, Western Saudi Arabia","volume":"17","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-4362.2000.00059.x","article-title":"Dissemination in Cutaneous Leishmaniasis Due to Leishmania Major in Different Ethnic Groups in Saudi Arabia","volume":"39","author":"Ghandour","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-4362.1989.tb04814.x","article-title":"Dissemination in Cutaneous Leishmaniasis. 3. Lymph Node Involvement","volume":"28","author":"Kubba","year":"1989","journal-title":"Int. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0035-9203(94)90158-9","article-title":"Sporotrichoid Cutaneous Leishmaniasis Due to Leishmania Major of Different Zymodemes in the Sudan and Saudi Arabia: A Comparative Study","volume":"88","author":"Gaafar","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/vbz.2017.2119","article-title":"Cutaneous Leishmaniasis in Saudi Arabia: A Comprehensive Overview","volume":"17","author":"Abuzaid","year":"2017","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, U., Pinart, M., Reveiz, L., and Alvar, J. (2008). Interventions for Old World Cutaneous Leishmaniasis. Cochrane Database Syst. Rev., CD005067.","DOI":"10.1002\/14651858.CD005067.pub3"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, U., Pinart, M., Rengifo-Pardo, M., Macaya, A., Alvar, J., and Tweed, J.A. (2009). Interventions for American Cutaneous and Mucocutaneous Leishmaniasis. Cochrane Database Syst. Rev., CD004834.","DOI":"10.1002\/14651858.CD004834.pub2"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7205\/MILMED-D-11-00161","article-title":"Evaluation of Thermotherapy for the Treatment of Cutaneous Leishmaniasis in Kabul, Afghanistan: A Randomized Controlled Trial","volume":"177","author":"Safi","year":"2012","journal-title":"Mil. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jtm.12089","article-title":"LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014","volume":"21","author":"Blum","year":"2014","journal-title":"J. Travel Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-9292-6-3","article-title":"Consultative Meeting to Develop a Strategy for Treatment of Cutaneous Leishmaniasis. Institute Pasteur, Paris. 13\u201315 June 2006","volume":"6","author":"Modabber","year":"2007","journal-title":"Kinetoplastid Biol. Dis."},{"key":"ref_45","unstructured":"(2023, June 21). Report of the Fifth Consultative Meeting on Leishmania\/HIV Coinfection. Available online: https:\/\/www.who.int\/publications-detail-redirect\/WHO-CDS-NTD-IDM-2007.5."},{"key":"ref_46","unstructured":"WHO Expert Committee on the Control of the Leishmaniases, and World Health Organization Control of the Leishmaniases (2012). Report of a Meeting of the WHO Expert Commitee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010. [Control de las Leishmaniasis: Informe de una Reuni\u00f3n del Comit\u00e9 de Expertos de la OMS sobre el Control de las Leishmaniasis, Ginebra, 22 a 26 de marzo de 2010], WHO."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00001432-200104000-00007","article-title":"Management of Cutaneous Leishmaniasis","volume":"14","author":"Hepburn","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0738-081X(99)00049-8","article-title":"Treatment of Cutaneous Leishmaniasis: Retrospectives and Advances for the 21st Century","volume":"17","author":"Moskowitz","year":"1999","journal-title":"Clin. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s40265-013-0132-1","article-title":"Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis","volume":"73","year":"2013","journal-title":"Drugs"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or Systemic Treatment for New World Cutaneous Leishmaniasis? Re-Evaluating the Evidence for the Risk of Mucosal Leishmaniasis","volume":"4","author":"Blum","year":"2012","journal-title":"Int. Health"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of Miltefosine and Meglumine Antimoniate for the Treatment of Zoonotic Cutaneous Leishmaniasis (ZCL) by a Randomized Clinical Trial in Iran","volume":"103","author":"Mohebali","year":"2007","journal-title":"Acta Trop."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.1992.tb00001.x","article-title":"Terbinafine: Mode of Action and Properties of the Squalene Epoxidase Inhibition","volume":"126","author":"Ryder","year":"1992","journal-title":"Br. J. Dermatol"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0140-6736(92)92265-H","article-title":"Loss of Taste and Terbinafine","volume":"340","author":"Ottervanger","year":"1992","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/bmj.306.6872.248-a","article-title":"Hepatitis Associated with Terbinafine Treatment","volume":"306","author":"Lowe","year":"1993","journal-title":"BMJ"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.1994.tb08573.x","article-title":"Terbinafine and Erythema Multiforme","volume":"131","author":"McGregor","year":"1994","journal-title":"Br. J. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2340\/0001555574391392","article-title":"Toxic Epidermal Necrolysis and Erythema Multiforme Following Therapy with Terbinafine","volume":"74","author":"Carstens","year":"1994","journal-title":"Acta Derm. Venereol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0190-9622(09)80049-2","article-title":"Neutropenia and Pancytopenia Associated with Oral Terbinafine","volume":"31","author":"Kovacs","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4314\/tjpr.v10i3.2","article-title":"Therapeutic Efficacy Evaluation of Metronidazole and Some Antifungal Agents with Meglumine Antimoniate on Visceral Leishmaniasis by Real-Time Light-Cycler (LC) PCR in BALB\/c Mice","volume":"10","author":"Bahashwan","year":"2011","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_60","first-page":"1","article-title":"Comparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial","volume":"10","author":"Farajzadeh","year":"2015","journal-title":"Iran. J. Parasitol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Bezemer, J.M., van der Ende, J., Limpens, J., de Vries, H.J.C., and Schallig, H.D.F.H. (2021). Safety and Efficacy of Allylamines in the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249628"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative Study of the Efficacy of Combined Cryotherapy and Intralesional Meglumine Antimoniate (Glucantime) vs. Cryotherapy and Intralesional Meglumine Antimoniate (Glucantime) Alone for the Treatment of Cutaneous Leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-4362.2002.01527.x","article-title":"Treatment of Cutaneous Leishmaniasis with a Combination of Allopurinol and Low-Dose Meglumine Antimoniate","volume":"41","author":"Momeni","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpddr.2019.08.002","article-title":"The Combination Therapy of Meglumine Antimoniate and Oxiranes (Epoxy-\u03b1-Lapachone and Epoxymethyl-Lawsone) Enhance the Leishmanicidal Effect in Mice Infected by Leishmania (Leishmania) Amazonensis","volume":"10","author":"Veloso","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1179\/000349803225001373","article-title":"The Efficacy of Treatment with Intralesional Meglumine Antimoniate Alone, Compared with That of Cryotherapy Combined with the Meglumine Antimoniate or Intralesional Sodium Stibogluconate, in the Treatment of Cutaneous Leishmaniasis","volume":"97","author":"Asilian","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","article-title":"Comparison of Intralesional Meglumine Antimoniate, Cryotherapy and Their Combination in the Treatment of Cutaneous Leishmaniasis","volume":"45","author":"Salmanpour","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/cid\/ciw742","article-title":"Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0035-9203(93)90030-T","article-title":"The Clinical and Immunological Spectrum of American Cutaneous Leishmaniasis","volume":"87","author":"Convit","year":"1993","journal-title":"Trans. R. Soc. Trop. Med. Hyg."}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/8\/9\/443\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:48:13Z","timestamp":1760129293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/8\/9\/443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,10]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["tropicalmed8090443"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed8090443","relation":{},"ISSN":["2414-6366"],"issn-type":[{"type":"electronic","value":"2414-6366"}],"subject":[],"published":{"date-parts":[[2023,9,10]]}}}